19-03-2025
Investor AB Unit to Buy Nova Biomedical in $2.2 Billion Deal
A unit of Investor AB, the investment firm controlled by the Wallenberg family, has struck an agreement to acquire Nova Biomedical for an enterprise value of $2.2 billion.
The merger with the acquiring unit, US-based Advanced Instruments, will create a portfolio of products serving the biopharmaceutical and clinical markets in more than 100 countries, according to a statement on Wednesday. For the full year 2024, the combined business generated sales of $621 million with an adjusted profit margin of about 30%.
